Needle-free injector moves closer to market
Aradigm has selected the final design configuration for its Intraject needle-free drug delivery system, allowing the company to press ahead with plans to commercialise the device.
Archives for February 11, 2004
AstraZeneca CEO blasts parallel importers
Sir Tom McKillop, chief executive of AstraZeneca, has delivered a stinging attack on parallel trade in pharmaceuticals as a factor that is contributing to the ground lost by European pharmaceutical companies to their US peers over the last 10 years.
Pharma still weak as DSM profits slide
DSM of the Netherlands saw its operating profit slump 23 per cent to €294 million last year, hit by higher raw material costs and declining sales of its life sciences products.
Major advance for minor ingredients?
Germany's Azo has developed a new automated system for dosing additives and minor ingredients in the pharmaceutical production process that should allow companies to make cost savings.